Name: Smoking Cessation Aids Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4165
Price: 4350 USD
Availability: InStock

Smoking Cessation Aids Market Size Share Growth Opportunities and Forecast 2022

Smoking Cessation Aids Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by Product</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising awareness about smoking cessation therapy</li>
				<li>Rising addiction of tobacco smoking</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>High cost associated with smoking cessation</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>PEST Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Nicotine Replacement Therapy*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
			<li>NRT Gum</li>
			<li>NRT lozenges</li>
			<li>NRT Inhalers</li>
			<li>NRT Patches</li>
			<li>Nicotine nasal sprays</li>
		</ol>
		</li>
		<li>Medication
		<ol>
			<li>Bupropion</li>
			<li>Varenicline</li>
			<li>Electronic Cigarettes</li>
			<li>Heat-not-burn Tobacco Products</li>
			<li>Others</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment</li>
			<li>Market Attractiveness Index, By Distribution Channel Segment</li>
		</ol>
		</li>
		<li>Retail Pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Hospital Pharmacies</li>
		<li>Online Pharmacies</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Cipla Ltd*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Takeda Pharmaceutical Company Limited</li>
		<li>NJOY</li>
		<li>Pfizer Inc</li>
		<li>GlaxoSmithKline Plc</li>
		<li>Dr. Reddy&#39;s Laboratories</li>
		<li>Juul Labs</li>
		<li>Glenmark</li>
		<li>Perrigo Company plc</li>
		<li>Johnson and Johnson Services, Inc</li>
		<li>Imperial Brand(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 1 Global Smoking Cessation Aids Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)

Table 2 Global Smoking Cessation Aids Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)

Table 3 Global Smoking Cessation Aids Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 4 Global Smoking Cessation Aids Market Value, By Product, 2021, 2025 &amp; 2029 ($ Million)

Table 5 Global Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 6 Global Smoking Cessation Aids Market Value, By Distribution Channel, 2021, 2025 &amp; 2029 ($ Million)

Table 7 Global Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 8 Global Smoking Cessation Aids Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 9 Global Smoking Cessation Aids Market Value, By Region, 2019-2029 ($ Million)

Table 10 North America Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 11 North America Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 12 North America Smoking Cessation Aids Market Value, By Country, 2019-2029 ($ Million)

Table 13 South America Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 14 South America Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 15 South America Smoking Cessation Aids Market Value, By Country, 2019-2029 ($ Million)

Table 16 Europe Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 17 Europe Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 18 Europe Smoking Cessation Aids Market Value, By Country, 2019-2029 ($ Million)

Table 19 Asia-Pacific Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 20 Asia-Pacific Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 21 Asia-Pacific Smoking Cessation Aids Market Value, By Country, 2019-2029 ($ Million)

Table 22 Middle East &amp; Africa Smoking Cessation Aids Market Value, By Product, 2019-2029 ($ Million)

Table 23 Middle East &amp; Africa Smoking Cessation Aids Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 24 Takeda Pharmaceutical Company Limited: Overview

Table 25 Takeda Pharmaceutical Company Limited: Product Portfolio

Table 26 Takeda Pharmaceutical Company Limited: Key Developments

Table 27 NJOY: Overview

Table 28 NJOY: Product Portfolio

Table 29 NJOY: Key Developments

Table 30 Pfizer Inc: Overview

Table 31 Pfizer Inc: Product Portfolio

Table 32 Pfizer Inc: Key Developments

Table 33 GlaxoSmithKline Plc: Overview

Table 34 GlaxoSmithKline Plc: Product Portfolio

Table 35 GlaxoSmithKline Plc: Key Developments

Table 36 Dr. Reddy&#39;s Laboratories: Overview

Table 37 Dr. Reddy&#39;s Laboratories: Product Portfolio

Table 38 Dr. Reddy&#39;s Laboratories: Key Developments

Table 39 Juul Labs: Overview

Table 40 Juul Labs: Product Portfolio

Table 41 Juul Labs: Key Developments

Table 42 Glenmark: Overview

Table 43 Glenmark: Product Portfolio

Table 44 Glenmark: Key Developments

Table 45 Perrigo Company plc: Overview

Table 46 Perrigo Company plc: Product Portfolio

Table 47 Perrigo Company plc: Key Developments

Table 48 Johnson and Johnson Services, Inc: Overview

Table 49 Johnson and Johnson Services, Inc: Product Portfolio

Table 50 Johnson and Johnson Services, Inc: Key Developments

Table 51 Imperial Brand: Overview

Table 52 Imperial Brand: Product Portfolio

Table 53 Imperial Brand: Key Developments

Table 54 Cipla Ltd: Overview

Table 55 Cipla Ltd: Product Portfolio

Table 56 Cipla Ltd: Key Development

List of Figures

Figure 1 Global Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 2 Global Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 3 Global Smoking Cessation Aids Market Share, By Region, 2021 &amp; 2029 (%)

Figure 4 Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 5 Global Smoking Cessation Aids Market Y-o-Y Growth, By Product, 2021-2029 (%)

Figure 6 Nicotine Replacement Therapy: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 7 Medications: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 8 Electronic Cigarettes: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 9 Heat-not-burn Tobacco Products: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 10 Others: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 11 Global Smoking Cessation Aids Market Y-o-Y Growth, By Distribution Channel, 2021-2029 (%)

Figure 12 Hospital Pharmacies: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 13 Retail Pharmacies: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 14 Online Pharmacies: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 15 Others: Global Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 16 Global Smoking Cessation Aids Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 17 North America Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 18 North America Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 19 North America Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 20 North America Smoking Cessation Aids Market Share, By Country, 2021 &amp; 2029 (%)

Figure 21 South America Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 22 South America Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 23 South America Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 24 South America Smoking Cessation Aids Market Share, By Country, 2021 &amp; 2029 (%)

Figure 25 Europe Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 26 Europe Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 27 Europe Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 28 Europe Smoking Cessation Aids Market Share, By Country, 2021 &amp; 2029 (%)

Figure 29 Asia-Pacific Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 30 Asia-Pacific Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 31 Asia-Pacific Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 32 Asia-Pacific Smoking Cessation Aids Market Share, By Country, 2021 &amp; 2029 (%)

Figure 33 Middle East &amp; Africa Smoking Cessation Aids Market Value, 2019-2029 ($ Million)

Figure 34 Middle East &amp; Africa Smoking Cessation Aids Market Share, By Product, 2021 &amp; 2029 (%)

Figure 35 Middle East &amp; Africa Smoking Cessation Aids Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 36 Takeda Pharmaceutical Company Limited: Financials

Figure 37 NJOY: Financials

Figure 38 Pfizer Inc: Financials

Figure 39 GlaxoSmithKline Plc: Financials

Figure 40 Dr. Reddy&#39;s Laboratories: Financials

Figure 41 Juul Labs: Financials

Figure 42 Glenmark: Financials

Figure 43 Perrigo Company plc: Financials

Figure 44 Johnson and Johnson Services, Inc: Financials

Figure 45 Imperial Brand: Financials

Figure 46 Cipla Ltd: Financials